BACKGROUND: The aim of our experimental work was to assess morphological changes of arterial wall that arise during different thawing protocols of a cryopreserved human aortic root allograft (CHARA) arterial wall. METHODS: The experiment was performed on CHARAs. Two thawing protocols were tested: 1, CHARAs were thawed at a room temperature at +23°C; 2, CHARAs were placed directly into a water bath at +37°C. MICROSCOPIC SAMPLES PREPARATION: After fixation, all samples were washed in distilled water for 5 min, and dehydrated in a graded ethanol series (70, 85, 95, and 100%) for 5 min at each level. The tissue samples were then immersed in 100% hexamethyldisilazane for 10 minutes and air dried in an exhaust hood at room temperature. Processed samples were mounted on stainless steel stubs, coated with gold. RESULTS: Thawing protocol 1: All 6 (100%) samples showed loss of the endothelium and damage to the subendothelial layers with randomly dispersed circular defects and micro-fractures without smooth muscle cells contractions in the tunica media. Thawing protocol 2: All 6 (100%) samples showed loss of endothelium from the luminal surface, longitudinal corrugations in the direction of blood flow caused by smooth muscle cells contractions in the tunica media with frequent fractures in the subendothelial layer. CONCLUSION: All the samples thawed at the room temperature showed smaller structural damage to the CHARA arterial wall with no smooth muscle cell contraction in tunica media when compared to the samples thawed in a water bath.

2nd Department of Cardiovascular Surgery General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

2nd Internal Department of Cardiology and Angiology General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Anatomy Charles University Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Department of Cardiovascular Surgery Faculty Hospital Motol and 2nd Faculty of Medicine Charles University Prague Czech Republic

Tissue Bank Faculty Hospital Hradec Kralove Charles University Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Transplant Center and Department of Cardiac Surgery University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark L, et al. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet. 2010. August 14; 376(9740):524–31. Epub 2010 Aug 3. 10.1016/S0140-6736(10)60828-8 PubMed DOI

Jashari R, Van Hoeck B, Ngakam R, Goffin Y, Fan Y. Banking of cryopreserved arterial allografts in Europe: 20 years of operation in the European Homograft Bank (EHB) in Brussels. Cell Tissue Bank. 2013. December; 14(4):589–99. Epub 2013 Jan 11 10.1007/s10561-012-9359-4 PubMed DOI

Perrotta S, Aljassim O, Jeppsson A, Bech-Hanssen O, Svensson G. Survival and quality of life after aortic root replacement with homografts in acute endocarditis. Ann Thorac Surg. 2010. December; 90(6):1862–7. 10.1016/j.athoracsur.2010.06.100 PubMed DOI

Ross DN. Homograft replacement of the aortic valve. Lancet 1962; 2:487 PubMed

Brewin EG. The use of tissue transplants in the surgery of cardiac valve disease- an experimental study. Guy’s Hospital Reports 1956; 105:328–329. PubMed

Merin G, McGoon DC. Reoperation after insertion of aortic homograft as a right ventricular outflow tract. Ann Thorac Surg. 1973. August; 16(2):122–6. PubMed

Brockbank KG, Schenke-Layland K, Greene ED, Chen Z, Fritze O, Schleicher M, et al. Ice-free cryopreservation of heart valve allografts: better extracellular matrix preservation in vivo and preclinical results. Cell Tissue Bank. 2012. December; 13(4):663–71. Epub 2012 Jan 3. 10.1007/s10561-011-9288-7 PubMed DOI

Gerson CJ, Elkins RC, Goldstein S, Heacox AE. Structural integrity of collagen and elastin in SynerGraft decellularized-cryopreserved human heart valves. Cryobiology. 2012. February; 64(1):33–42. Epub 2011 Nov 19. 10.1016/j.cryobiol.2011.11.001 PubMed DOI

Moussa M, Dumont F, Perrier-Cornet JM, Gervais P. Cell inactivation and membrane damage after long-term treatments at sub-zero temperature in the supercooled and frozen states. Biotechnol Bioeng. 2008. December 15; 101(6):1245–55. 10.1002/bit.21981 PubMed DOI

Shahmansouri N, Cartier R, Mongrain R. Characterization of the toughness and elastic properties of fresh and cryopreserved arteries. J Biomech. 2015. July 16; 48(10):2205–9. Epub 2015 Apr 7. 10.1016/j.jbiomech.2015.03.033 PubMed DOI

Krs O, Burkert J, Slízová D, Kobylka P, Spatenka J. Allograft semilunar cardiac valves processing and cryopreservation—morphology inscanning electron microscope. Cell Tissue Bank. 2006; 7(3):167–73. 10.1007/s10561-004-1889-y PubMed DOI

M'Bengue-Gaye A, Fleury JP, Gerota J, Gueye L, Eugene M, Cisse F. Transplantation of cryopreserved carotids in the rabbit: effect of cryoprotective agents. Dakar Med. 1999; 44(2):180–5. PubMed

Huber AJ, Brockbank KG, Riemann I, Schleicher M, Schenke-Layland K, Fritze O, et al. Preclinical evaluation of ice-free cryopreserved arteries: structural integrity and hemocompatibility. 2012;196(3):262–70. Epub 2012 Mar 13. PubMed

Manaa J, Sraieb T, Khayat O, Ben Romdhane N, Hamida J, Amor A. The effect of cryopreservation on the structural and functional properties of human vascular allografts. Tunis Med. 2003; 81 Suppl 8:645–51. PubMed

Pasquinelli G, Pistillo MP, Ricci F, Buzzi M, Tazzari PL, Foroni L, et al. The "in situ" expression of human leukocyte antigen class I antigens is not altered by cryopreservation in human arterial allografts. Cell Tissue Bank. 2007; 8(3):195–203. Epub 2006 Oct 25. PubMed

Verghese S, Cherian KM. HLA expression in aortic and pulmonary homografts: effects of cryopreservation. Indian Heart J. 2002. Jul-Aug; 54(4):394–8. PubMed

Rodríguez M, Pascual G, Pérez-Köhler B, Cifuentes A, Garcia-Honduvilla N, Bellón JM, et al. Immune response to the long-term grafting of cryopreserved small-diameter arterial allografts. Histol Histopathol. 2012. July; 27(7):873–84. 10.14670/HH-27.873 PubMed DOI

Takkenberg JJ, Eijkemans MJ, van Herwerden LA, Steyerberg EW, Lane MM, Elkins RC, et al. Prognosis after aortic root replacement with cryopreserved allografts in adults. Ann Thorac Surg. 2003. May; 75(5):1482–9. PubMed

Preventza O, Mohamed AS, Cooley DA, Rodriguez V, Bakaeen FG, Cornwell LD, et al. Homograft use in reoperative aortic root and proximal aortic surgery for endocarditis: A 12-year experience in high-risk patients. J Thorac Cardiovasc Surg. 2014. September; 148(3):989–94. Epub 2014 Jun 14. 10.1016/j.jtcvs.2014.06.025 PubMed DOI

Jassar AS, Bavaria JE, Szeto WY, Moeller PJ, Maniaci J, Milewski RK, et al. Graft selection for aortic root replacement in complex active endocarditis: does it matter? Ann Thorac Surg. 2012. February; 93(2):480–7. Epub 2011 Dec 22. 10.1016/j.athoracsur.2011.09.074 PubMed DOI

Von Rossum A, Laher I, Choy JC. Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis. Front Immunol. 2015; 5:684 10.3389/fimmu.2014.00684 PubMed DOI PMC

Qin L, Yu L, Min W. Mouse models for graft arteriosclerosis. J Vis Exp.2013:e50290–e50290. 10.3791/50290 PubMed DOI PMC

Ziqiang X, Jingjun W, Jianjian Z, Yong L, Peng X. Tadalafil attenuates graft arteriosclerosis of aortic transplant in a rat model. Iran J Basic Med Sci. 2015. September; 18(9): 927–931. PubMed PMC

Vrtik M, Tesar PJ. Re-do aortic root replacement after an allograft aortic root replacement. Ann Thorac Surg. 2009. October; 88(4):1365–6. 10.1016/j.athoracsur.2008.12.100 PubMed DOI

Preventza O, Mohamed AS, Cooley DA, Rodriguez V, Bakaeen FG, Cornwell LD, et al. Homograft use in reoperative aortic root and proximal aortic surgery for endocarditis: A 12-year experience in high-risk patients. J Thorac Cardiovasc Surg. 2014. September; 148(3):989–94. Epub 2014 Jun 14. 10.1016/j.jtcvs.2014.06.025 PubMed DOI

Weymann A, Radovits T, Schmack B, Korkmaz S, Li S, Chaimow N, et al. Total aortic arch replacement: superior ventriculo-arterial coupling with decellularized allografts compared with conventional prostheses. PLoS One. 2014. July 31; 9(7):e103588 eCollection 2014. 10.1371/journal.pone.0103588 PubMed DOI PMC

Matia I, Fellmer P, Splith K, Varga M, Adamec M, Kämmerer I, et al. Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. Ann Transplant. 2014. May 12; 19:225–32. 10.12659/AOT.889870 PubMed DOI

Nakanishi T, Xu X, Wynn C, Yamada T, Pan F, Erickson L, et al. Absence of Activation-induced Cytidine Deaminase, a Regulator of Class SwitchRecombination and Hypermutation in B Cells, Suppresses Aorta Allograft Vasculopathy in Mice. Transplantation. 2015. August; 99(8):1598–605. 10.1097/TP.0000000000000688 PubMed DOI

Buzzi M, Guarino A, Gatto C, Manara S, Dainese L, Polvani G, et al. Residual antibiotics in decontaminated human cardiovascular tissues intended for transplantation and risk of falsely negative microbiological analyses. PLoS One. 2014. November 14; 9(11):e112679 eCollection 2014. 10.1371/journal.pone.0112679 PubMed DOI PMC

Cell Viability Assessment Using Fluorescence Vital Dyes and Confocal Microscopy in Evaluating Freezing and Thawing Protocols Used in Cryopreservation of Allogeneic Venous Grafts

The Effect of Different Thawing Rates on Cryopreserved Human Iliac Arteries Allograft's Structural Damage and Mechanical Properties

Influence of the new standardized clinical cryopreservation/slow thawing protocol on immunogenicity of arterial allografts in rats